MedPlus To Sell Over 500 Off-Patent Drugs At Huge Discounts

Hyderabad : MedPlus Health Services, which runs a chain of pharmacies, said it will be selling 500 off-patent therapeutic and chronic medicines under its own brand with a discount of 50-80 per cent.

Announcing this at a press conference on Wednesday, G Madhukar Reddy, managing director and chief executive officer, MedPlus, said the company tied up with multiple reputed pharmaceutical manufacturing companies to produce high quality off-patent medicines that enables the firm to pass on the benefit to the consumer.

“MedPlus will initially offer discounts on over 500 therapeutic and chronic medicines and will eventually extend discounts on more than 800 products in the next three months,” Reddy said.

These medicines will include over-the-counter (OTC) and prescription drugs used in treating various diseases such as hypertension, diabetes and kidney ailments, he said.

The 500 products currently being offered cover about 53 per cent of the therapeutic segments and the products will be sold under the MedPlus brand, he added.

Currently, it operates about 3,800 stores and has plans to add another 800 new pharmacies during 2023-24.  “Our size allows us to eliminate marketing, distribution and other retail costs and will pass on the benefits to customers,” he said.

  • Related Posts

    • Pharma
    • June 16, 2025
    • 94 views
    Natco API plant gets one observation from FDA

    Hyderabad: Drugmaker, Natco Pharma, Mekaguda-based Active Pharmaceutical Ingredients (API) plant has received one observation under the form 483 from the US Food and Drug Administration (FDA). In a stock exchange…

    • Pharma
    • June 16, 2025
    • 85 views
    Pharma department refuses to name 30 doctors in bribery tangle

    Thirty doctors who accepted foreign travel and hospitality worth Rs 1.9 crore from pharma company AbbVie in Feb-March 2024 have faced no action from NMC because the department of pharmaceuticals…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco API plant gets one observation from FDA

    Natco API plant gets one observation from FDA

    Pharma department refuses to name 30 doctors in bribery tangle

    Pharma department refuses to name 30 doctors in bribery tangle

    Delhi Police busts fake cancer drugs racket

    Delhi Police busts fake cancer drugs racket

    Sun Pharma appoints Kirti Ganorkar as the Managing Director

    Sun Pharma appoints Kirti Ganorkar as the Managing Director